Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gritstone Bio Inc (NQ: GRTS ) 0.5760 +0.0060 (+1.05%) Streaming Delayed Price Updated: 1:34 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Gritstone Bio Inc < Previous 1 2 Next > The Law Offices of Frank R. Cruz Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors June 11, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Gritstone bio, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the GRTS Class Action June 11, 2024 From Robbins LLP Via Business Wire GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! June 11, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc. June 11, 2024 From Bernstein Liebhard LLP Via GlobeNewswire GRITSTONE INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GRTS June 10, 2024 From The Rosen Law Firm, P.A. Via Business Wire Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against Gritstone Bio, Inc. June 08, 2024 From Robbins LLP Via GlobeNewswire Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 09, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite April 01, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates March 05, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates November 08, 2023 From Gritstone bio Via GlobeNewswire Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award October 12, 2023 From Genevant Sciences Via GlobeNewswire Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine October 11, 2023 From Gritstone bio Via GlobeNewswire Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million September 27, 2023 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates August 09, 2023 From Gritstone bio Via GlobeNewswire Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates May 11, 2023 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates March 09, 2023 From Gritstone bio Via GlobeNewswire InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Member December 05, 2022 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors December 05, 2022 From Predictive Oncology Inc. Via GlobeNewswire Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update November 03, 2022 From Gritstone bio Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
